WELLS FARGO & COMPANY/MN - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$2,828,769
-35.8%
110,715
-27.9%
0.00%0.0%
Q2 2023$4,405,105
+14.4%
153,595
-4.4%
0.00%0.0%
Q1 2023$3,850,493
+94.7%
160,638
+37.7%
0.00%0.0%
Q4 2022$1,977,909
-27.6%
116,622
-36.7%
0.00%0.0%
Q3 2022$2,731,000
-1.5%
184,288
+4.6%
0.00%0.0%
Q2 2022$2,773,000
-34.3%
176,149
+12.5%
0.00%0.0%
Q1 2022$4,222,000
-5.7%
156,619
+29.4%
0.00%0.0%
Q4 2021$4,478,000
-32.8%
120,994
-13.2%
0.00%0.0%
Q3 2021$6,664,000
+66.6%
139,457
+18.0%
0.00%0.0%
Q2 2021$4,000,000
-10.4%
118,218
+9.3%
0.00%0.0%
Q1 2021$4,466,000
-27.2%
108,132
-23.5%
0.00%0.0%
Q4 2020$6,133,000
+88.0%
141,372
+85.9%
0.00%0.0%
Q3 2020$3,263,000
+7.3%
76,051
+16.8%
0.00%0.0%
Q2 2020$3,042,000
+1308.3%
65,098
+310.5%
0.00%
Q1 2020$216,000
+980.0%
15,859
+740.0%
0.00%
Q4 2019$20,000
+122.2%
1,888
+121.9%
0.00%
Q3 2019$9,000
-18.2%
851
-27.0%
0.00%
Q2 2019$11,0001,1650.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders